Clean Slate: The Psychedelic Revolution in Healthcare with Maria Velkova

Aug 9, 2024

Maria Velkova, managing partner at Tabula Rasa Ventures, dives into the revolutionary use of psychedelics in therapy, particularly for veterans with unmet mental health needs. She highlights the historical stigma around psychedelics and the current shift toward acceptance. Velkova discusses the integration of psychedelic-assisted therapy into healthcare, the FDA's review of MDMA for PTSD, and the need for funding to expand these innovative treatments. With promising trial results, she advocates for a holistic approach to mental health that could transform care delivery.

Ask episode

Chapters

Transcript

Episode notes

Intro

00:00 • 3min

Psychedelics in Modern Therapy

02:38 • 27min

Navigating Funding Challenges in Innovative Healthcare

29:20 • 5min

MDMA and PTSD: Navigating FDA Approvals

34:48 • 21min

Navigating Professional and Personal Interests on Social Media

55:35 • 2min

Closing Thoughts on Community and Adaptation

57:40 • 2min

Send us a text

Maria Velkova, managing partner of Tabula Rasa Ventures, discusses the use of psychedelics in therapy and the work her organization is doing to support the space. She explains that psychedelic-assisted therapy is a novel care delivery model that combines traditional therapy with the use of psychedelic medicines. Velkova emphasizes the efficacy of these therapies, particularly for veterans who have high unmet needs. She also discusses the history of psychedelics and the negative connotations associated with them, as well as the current shift towards acceptance and understanding. The conversation explores the impact of psychedelics on the healthcare ecosystem and the potential for personalized, holistic, and disease-modifying approaches to mental health care. The conversation explores the role of money and investment in the psychedelic industry, the potential approval of MDMA-assisted therapy by the FDA, and the challenges and stigma surrounding psychedelic research and therapy. It emphasizes the need for capital to scale and provide broad patient access to innovative therapies.
As we await the FDA's decision on MDMA-assisted therapy, Maria shares promising Phase 3 trial results and discusses the broader applications of these treatments beyond veterans. Stay informed about the evolving landscape of psychedelic science, and gather valuable resources for further learning, including peer-reviewed journals and insightful platforms like Psychedelic Alpha and Double Blind. Maria also shares her top book recommendation, "The Myth of Normal" by Gabor Mate, and the impactful initiatives of Tabula Rasa and Energia, leaving us with a sense of hope and excitement for the future of mental health care.

Maria Velkova on LinkedIn
Tabula Rasa Ventures

NWO Intro with Boyd

March 25, 2025

Flow Learning Lab

Find us on X. @NoWayOutcast
Substack: The Whirl of ReOrientation

Want to develop your organization’s capacity for free and independent action (Organic Success)? Learn more and follow us at:
https://www.aglx.com/
https://www.youtube.com/@AGLXConsulting
https://www.linkedin.com/company/aglx-consulting-llc/
https://www.linkedin.com/in/briandrivera
https://www.linkedin.com/in/markjmcgrath1
https://www.linkedin.com/in/stevemccrone

Stay in the Loop. Don't have time to listen to the podcast? Want to make some snowmobiles? Subscribe to our weekly newsletter to receive deeper insights on current and past episodes.
Recent podcasts where you’ll also find Mark and Ponch:

The No Bell Podcast Episode 24
...